|
|
||||||||
Department of Cardiac Surgery, San Raffaele University Hospital, Via Olgettina 60, 20132 Milan, Italy
Received 3 September 2007; received in revised form 3 January 2008; accepted 8 January 2008.
* Corresponding author. Tel.: +39 0226437102; fax: +39 0226437125. (Email: michele.debonis{at}hsr.it).
Objective: To assess the evolution of tricuspid regurgitation (TR) in dilated cardiomyopathy (DCM) patients submitted to mitral repair for functional mitral regurgitation (MR). Methods: Ninety-one DCM patients (mean age 61 ± 11.3) submitted to MV repair (±tricuspid repair) for functional MR were included. Preoperative EF was 30.9 ± 6.5%, left ventricular (LV) end-diastolic volume 113 ± 31.5 ml/m2, LV end-systolic volume 81.8 ± 26.7 ml/m2, functional MR
3+/4+. TR was classified as
1+/4+ in 57 patients (62.6%), 2+/4+ in 21 (23%) and
3+/4+ in 13 (14.2%). Most of the patients were in NYHA class III or IV. A tricuspid annuloplasty was associated to mitral repair whenever preoperative TR was
3+. Therefore 13 patients (14.2%) underwent concomitant tricuspid annuloplasty whereas the remaining 78 (with preoperative TR
2+) did not. Results: At follow-up (mean 1.8 ± 1.2 years), 12% of the patients (11/91) had still 3–4+ TR due to failure of the tricuspid repair or progression of untreated
2+ TR. Freedom from TR
3+ was 78 ± 8.8% at 3.5 years. Among the 78 patients not submitted to tricuspid repair, 14 (18%) showed a progression of TR severity equal or greater than two grades. The multivariate analysis identified grade of TR at discharge (OR 5.4, p
= 0.01) and preoperative RV dysfunction (OR 19.6, p
= 0.02) as the only independent predictors of TR
3+/4+ at follow-up. Conclusions: A significant number of patients submitted to mitral repair for functional MR present
3+ TR at follow-up as consequence of progression of untreated TR or failure of tricuspid repair. A more aggressive and effective treatment of functional TR in this setting should be pursued.
Key Words: Functional tricuspid regurgitation Functional mitral regurgitation Dilated cardiomyopathy
This article has been cited by other articles:
![]() |
F. Onorati, G. Santarpino, D. Marturano, A. S. Rubino, E. Pasceri, S. Zinzi, G. Mascaro, L. Cristodoro, and A. Renzulli Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular function. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 341 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Mauro, A. Bivona, A. L. Iaco, M. Contini, M. Gagliardi, E. Varone, S. Gallina, and A. M. Calafiore Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shiran and A. Sagie Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J. Am. Coll. Cardiol., February 3, 2009; 53(5): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Wechsler Mitral valve surgery for functional mitral regurgitation: Should moderate to severe tricuspid regurgitation be treated? A propensity score analysis. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 267 - 268. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |